• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchOnkure Therapeutics
    Picture of Onkure Therapeutics logo

    OKUR — Onkure Therapeutics Share News

    $2.520.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    • Market Cap
      $102.05m
    • Enterprise Value
      -$74.34m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • OKUR Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    OKUR Dividends
    • Brief: Abingworth Llp Reports 7.7% Stake In Reneo Pharmaceuticals Inc As Of April 13, 2021 - SEC Filing

      20/04/2021 22:03
    • NASDAQ RESUMED AT 11:18 AM

      09/04/2021 16:18
    • NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:01 AM

      09/04/2021 09:01
    • Brief: Reneo Pharmaceuticals Announces Pricing Of Initial Public Offering

      09/04/2021 02:45
    • Brief: Reneo Pharmaceuticals Inc Sees IPO Of 6.3 Mln Shares Of Common Stock Priced To Be Between $15 And $17 Per Share

      05/04/2021 14:20
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.